Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects - NUHS Investigational Medicine Unit

Study Details	To determine the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a Single Ascending Dose (SAD) of CAN106 Administered Intravenously (IV) in Healthy Subjects
Protocol Number	CAN106
Phase	I
Therapeutic Area	Haematology
Subject Types	Healthy volunteer
Indication	PNH
Principal Investigator	Dr Khoo Chin Meng
Investigator Product / Device	CAN106
Sponsor	CARE Pharma Shanghai Ltd